首届国际Rome共识会议:肠道菌群与粪菌移植在炎症性肠病中的应用
该共识由国际专家组通过电子Delphi投票制定,针对粪菌移植治疗炎症性肠病的四个关键议题——发病机制与原理、供体选择与生物样本库、粪菌移植实践、未来研究考量——给出基于现有证据的声明与推荐,旨在推动标准化实践。
要点
- 共识涵盖粪菌移植治疗炎症性肠病的发病机制与原理、供体选择与生物样本库、实践操作及未来研究方向。
- 现有随机对照试验在设计(剂量、途径、频率、安慰剂类型、终点)上存在较大差异,结局高度依赖供体与受体因素。
- 专家组通过电子Delphi流程投票形成声明,最终经全体共识会议产生推荐意见。
核心结论
- 专家组基于最佳现有证据提供了具体声明与推荐,旨在为将粪菌移植推广为炎症性肠病公认治疗策略提供指导与通用标准。
研究设计与样本
- 国际专家组多次召开会议,通过深入评估现有及已发表数据制定循证指南。
- 25名炎症性肠病、免疫学和微生物学专家组成不同工作组,就粪菌移植在炎症性肠病中的关键议题撰写声明。
- 声明由全体成员通过电子Delphi流程评估和投票,最终召开全体共识会议并产生推荐指南。
主要发现
- 近期发表的粪菌移植治疗炎症性肠病(尤其溃疡性结肠炎)的随机对照试验在给药剂量、途径和频率、安慰剂类型及评估终点方面存在较大差异。
- 尽管总体结局似乎有前景,但高度依赖供体与受体因素。
关键数值与推荐
- 共识声明覆盖四大关键议题:(A)发病机制与原理,(B)供体选择与生物样本库,(C)粪菌移植实践,(D)未来研究与前景的考量。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, have recently been published, but with major variations in study design. These include differences in administered dose, route and frequency of delivery, type of placebo and evaluated endpoints. Although the overall outcomes appear to be promising, they are highly dependent on both donor and recipient factors. OBJECTIVE: To develop concensus-based statements and recommendations for the evaluation, management and potential treatment of IBD using FMT in order to move towards standardised practices. DESIGN: An international panel of experts convened several times to generate evidence-based guidelines by performing a deep evaluation of currently available and/or published data. Twenty-five experts in IBD, immunology and microbiology collaborated in different working groups to provide statements on the following key issues related to FMT in IBD: (A) pathogenesis and rationale, (B) donor selection and biobanking, (C) FMT practices and (D) consideration of future studies and perspectives. Statements were evaluated and voted on by all members using an electronic Delphi process, culminating in a plenary consensus conference and generation of proposed guidelines. RESULTS AND CONCLUSIONS: Our group has provided specific statements and recommendations, based on best available evidence, with the end goal of providing guidance and general criteria required to promote FMT as a recognised strategy for the treatment of IBD.
引用
- Lopetuso LR, Deleu S, Godny L, et al. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut. 2023. PMID: 37339849. doi:10.1136/gutjnl-2023-329948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。